Infusional Devices for Cancer Pain

Publisher： John Wiley & Sons Inc

E-ISSN： 1525-1403|6|3|195-196

ISSN： 1094-7159

Source： NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol.6, Iss.3, 2003-07, pp. : 195-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 113-119

Karger

Access to resources Recommend Favorite

Weekly Gemcitabine and 24-Hour Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase I–II Study

By  

Oncology, Vol. 64, Iss. 2, 2003-02 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer

By  

Oncology, Vol. 70, Iss. 1, 2006-03 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Infusional 5-Fluorouracil and Mitomycin C: An Effective Regimen in the Treatment of Advanced Gastric Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 3, 2005-03 ,pp. : 128-132

Karger

Access to resources Recommend Favorite

Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3429-3435

John Wiley & Sons Inc

Access to resources Recommend Favorite